The NIH-Moderna Vaccine: Public Science, Private Profit, and Lessons for the Future

Journal of Law, Medicine and Ethics 51 (S2):35-40 (2023)
  Copy   BIBTEX

Abstract

This commentary highlights the scientific history of the NIH-Moderna COVID-19 vaccine and corroborates Sarpatwari’s theme of private capture of value created by the public. The commentary also identifies missteps by the Trump and Biden Administrations and offers policy recommendations: better contracts with and incentives for pharmaceutical manufacturers and a not-for-profit “public option” for pharmaceutical development.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,610

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

The Private Cosmology of Public Disgust.Michael Springer - 2021 - Philosophical Papers 50 (3):465-503.
From Private to Public: Is the Public/Private Distinction Gender Discrimination? [REVIEW]Dana Tabrea - 2010 - Meta: Research in Hermeneutics, Phenomenology, and Practical Philosophy 2 (2):562-567.

Analytics

Added to PP
2024-03-05

Downloads
8 (#1,311,508)

6 months
8 (#351,492)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references